Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.
On July 15, 2025, the U.S. Food and Drug Administration reported the detection of 7 hydroxymitragynine in a product identified as Edp 7oh mitragyna speciosa extract. This incident has been classified under the category of "Other incident," highlighting its significance within regulatory oversight.
The presence of 7 hydroxymitragynine, a compound related to mitragynine, raises concerns regarding the composition of herbal extracts derived from the mitragyna speciosa plant. The detection occurred in the United States of America, prompting further scrutiny into the manufacturing and quality control processes associated with this extract.
As the situation develops, it is essential for consumers and stakeholders to remain informed about the implications of such findings. The U.S. Food and Drug Administration continues to monitor the situation closely, ensuring that appropriate measures are taken to address any potential issues related to product safety and compliance.
This incident serves as a reminder of the importance of thorough testing and regulation in the herbal supplement industry, particularly concerning products that may contain psychoactive compounds. The ongoing evaluation of the Edp 7oh mitragyna speciosa extract will be crucial in determining its future availability and safety for consumers.
- Incident: 7 hydroxymitragynine has been detected in Edp 7oh mitragyna speciosa extract.
- Date: 2025-07-15
- Product: Edp 7oh mitragyna speciosa extract
- Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Origin of issue: United States of America
- Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Incident Category: Other incident
- Hazard Category: null
- Source: U.S. Food and Drug Administration
For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software.
Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)
